IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Net Short-Term Debt Issued (Repaid) (2026)

Updated

Analysis

IRulya Therapeutics (IRLA) Net Short-Term Debt Issued (Repaid) (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -4.36 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -682.00 Mn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -24.00 Mn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.55 Mn
API Access

IRulya Therapeutics Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=IRLA&period=max&api_key=YOUR_API_KEY